ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1191

Retinal Vessel Morphometry Associations with Polymyalgia Rheumatica; Findings from the European Prospective Investigation of Cancer (EPIC) in Norfolk

Max Yates1, Shabina Hayat2, Robert N. Luben3, Roshan Welikala4, Alicja Rudnicka5, Christopher Owen5, Sarah Barman4, Eoin O'Sullivan6, Sarah Mackie7, Richard Watts1, Paul Foster8, Kay-Tee Khaw3, Nick Wareham3 and Alex J Macgregor9, 1Norwich Medical School, University of East Anglia, Norwich, United Kingdom, 2Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom, 3Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, 4Faculty of Science, Engineering and Computing, University of Kingston, London, United Kingdom, 5Population Health Research Institute, St George's University of London, London, United Kingdom, 6Ophthalmology, Kings College Hospital, London, United Kingdom, 7NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, University of Leeds, Leeds, United Kingdom, 8Division of Epidemiology and Genetics, University College London, London, United Kingdom, 9Rheumatology, Norfolk and Norwich University Hospital, Norwich, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Epidemiologic methods, outcomes and polymyalgia rheumatica

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Epidemiology and Public Health - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Increasing evidence suggests that characteristic changes in retinal vessel morphometry are biomarkers for vascular health. Polymyalgia Rheumatica (PMR) has been associated with increased risk of vascular disease in some epidemiological studies, but to date there are limited data on objective changes in blood vessels in patients with this condition. This study examines the retinal vessel morphology of individuals with PMR in a population-based cohort.

Methods:  The study was conducted in participants diagnosed with PMR identified from the EPIC-Norfolk cohort, a population-based study of 25,639 men and women aged 40-79 years, recruited between 1993-1997. Diagnoses of PMR were established through electronic linkage to laboratory, hospital care episodes and questionnaire responses, supplemented by chart reviews during follow-up to 2015. In 2006-2011 digital retinal photography was undertaken and analysed using a validated automated system, which measures vessel width in arterioles and venules respectively. Gaussian modelling was used to determine vessel widths. An ensemble classifier of bagged decision trees was used to classify vessels into probabilities of being either venules or arterioles. Associations were analysed using multi-level linear regression, adjusted for gender and age, allowing for within person clustering.

Results:  In total, 10,494 good quality images were obtained from 5959 participants were analysed. Median arteriolar and venular widths were 68.5µm (5th to 95th centiles 49.4, 91.0µm), and 99.1µm (5th to 95th centiles 83.1, 116.4µm) respectively. There were 298 incident diagnoses of PMR (72.5% female) during the follow-up period. The median age at diagnosis was 75.6 years of which 140 had good quality retinal imaging. Those with PMR diagnoses showed wider venules compared to those without disease (mean difference 3.1µm. 95% CI 1.1,5.1µm); there were no appreciable differences in arteriolar diameter (mean difference 0.3µm, 95% CI -2.1,2.8 µm).

Conclusion:  These results provide the first objective evidence of a biomarker for vascular health in patients with PMR, a disease in which there is an absence of adequate clinical process and outcome measures. Although limited by the cross-sectional design, the findings indicate that retinal morphometric analysis could prove a useful monitoring tool for vascular complications in patients with rheumatic disease.


Disclosure: M. Yates, None; S. Hayat, None; R. N. Luben, None; R. Welikala, None; A. Rudnicka, None; C. Owen, None; S. Barman, None; E. O'Sullivan, None; S. Mackie, None; R. Watts, None; P. Foster, None; K. T. Khaw, None; N. Wareham, None; A. J. Macgregor, None.

To cite this abstract in AMA style:

Yates M, Hayat S, Luben RN, Welikala R, Rudnicka A, Owen C, Barman S, O'Sullivan E, Mackie S, Watts R, Foster P, Khaw KT, Wareham N, Macgregor AJ. Retinal Vessel Morphometry Associations with Polymyalgia Rheumatica; Findings from the European Prospective Investigation of Cancer (EPIC) in Norfolk [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/retinal-vessel-morphometry-associations-with-polymyalgia-rheumatica-findings-from-the-european-prospective-investigation-of-cancer-epic-in-norfolk/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/retinal-vessel-morphometry-associations-with-polymyalgia-rheumatica-findings-from-the-european-prospective-investigation-of-cancer-epic-in-norfolk/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology